BerandaNTRA • NASDAQ
add
Natera Inc
Tutup sebelumnya
$236,49
Rentang hari
$236,53 - $241,28
Rentang tahun
$125,38 - $241,28
Kapitalisasi pasar
33,02 M USD
Volume Rata-Rata
1,59 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 592,18 jt | 34,66% |
Biaya operasional | 481,96 jt | 54,93% |
Penghasilan bersih | -87,54 jt | -177,11% |
Margin laba bersih | -14,78 | -105,85% |
Penghasilan per saham | -0,64 | -146,15% |
EBITDA | -87,28 jt | -180,31% |
Tarif pajak efektif | -0,24% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,04 M | 13,02% |
Total aset | 1,82 M | 14,49% |
Total liabilitas | 569,29 jt | -20,09% |
Total ekuitas | 1,25 M | — |
Saham yang beredar | 138,01 jt | — |
Harga terhadap nilai buku | 25,99 | — |
Tingkat pengembalian aset | -13,63% | — |
Tingkat pengembalian modal | -16,86% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -87,54 jt | -177,11% |
Kas dari operasi | 59,39 jt | 14,68% |
Kas dari investasi | -19,90 jt | -146,79% |
Kas dari pembiayaan | 1,94 jt | 12,50% |
Perubahan kas bersih | 41,42 jt | -56,88% |
Arus kas bebas | 71,33 jt | 77,49% |
Tentang
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Didirikan
1 Jan 2004
Kantor pusat
Situs
Karyawan
4.429
